These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1845228)

  • 1. Oxygen radicals and neuropsychiatric illness. Some speculations.
    Lohr JB
    Arch Gen Psychiatry; 1991 Dec; 48(12):1097-106. PubMed ID: 1845228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical involvement in neuropsychiatric illnesses.
    Lohr JB; Browning JA
    Psychopharmacol Bull; 1995; 31(1):159-65. PubMed ID: 7675980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.
    Cadet JL
    Med Hypotheses; 1988 Sep; 27(1):59-63. PubMed ID: 3060706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radicals in brain metabolism and pathology.
    Evans PH
    Br Med Bull; 1993 Jul; 49(3):577-87. PubMed ID: 8221024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free radicals and antioxidants.
    Evans PH; Klinowski J
    Lancet; 1994 Nov; 344(8934):1441. PubMed ID: 7968106
    [No Abstract]   [Full Text] [Related]  

  • 6. Metals and free radicals in neurodegeneration.
    Olanow CW; Arendash GW
    Curr Opin Neurol; 1994 Dec; 7(6):548-58. PubMed ID: 7866588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen free radicals and brain dysfunction.
    Jesberger JA; Richardson JS
    Int J Neurosci; 1991 Mar; 57(1-2):1-17. PubMed ID: 1938149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radical damage and oxidative stress in Huntington's disease.
    Borlongan CV; Kanning K; Poulos SG; Freeman TB; Cahill DW; Sanberg PR
    J Fla Med Assoc; 1996 May; 83(5):335-41. PubMed ID: 8666972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
    Nemeroff CB; Bissette G
    Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in neurodegenerative diseases and cancer.
    de Moura MB; dos Santos LS; Van Houten B
    Environ Mol Mutagen; 2010 Jun; 51(5):391-405. PubMed ID: 20544881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?
    Halliwell B
    Acta Neurol Scand Suppl; 1989; 126():23-33. PubMed ID: 2694733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis.
    Volicer L; Crino PB
    Neurobiol Aging; 1990; 11(5):567-71. PubMed ID: 2146522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species and the neurodegenerative disorders.
    Knight JA
    Ann Clin Lab Sci; 1997; 27(1):11-25. PubMed ID: 8997453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine as a neuromodulator in neurological diseases.
    Boison D
    Curr Opin Pharmacol; 2008 Feb; 8(1):2-7. PubMed ID: 17942368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of awareness in neuropsychiatric syndromes: an update.
    Flashman LA
    Curr Psychiatry Rep; 2002 Oct; 4(5):346-53. PubMed ID: 12230963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis.
    Tabet N; Mantle D; Orrell M
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory peptides in animal paradigms of neuropsychiatric illness.
    Diamond BI; Borison RL
    Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioenergetic and oxidative stress in neurodegenerative diseases.
    Bowling AC; Beal MF
    Life Sci; 1995; 56(14):1151-71. PubMed ID: 7475893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical mechanisms in schizophrenia and tardive dyskinesia.
    Cadet JL; Kahler LA
    Neurosci Biobehav Rev; 1994; 18(4):457-67. PubMed ID: 7708360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.